Entering text into the input field will update the search result below

Diffusion Pharma completes early-stage study of TSC in COVID-19, shares up 18%

Feb. 16, 2021 7:59 AM ETCervoMed Inc. (CRVO) StockCRVOBy: SA News Team
  • Diffusion Pharmaceuticals (NASDAQ:DFFN) jumps 18% premarket in reaction to the announcement of completion and reporting topline data from Phase 1b clinical trial of its novel, trans sodium crocetinate (TSC), in hospitalized COVID-19 patients with confirmed hypoxemia.
  • The primary objective was to evaluate

Recommended For You

More Trending News

About CRVO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CRVO--
CervoMed Inc.